Michael Rose to Receptor Protein-Tyrosine Kinases
This is a "connection" page, showing publications Michael Rose has written about Receptor Protein-Tyrosine Kinases.
Connection Strength
0.021
-
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 2011 Jun; 82(6):671-3.
Score: 0.021
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.